相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Oral Venglustat in Healthy Volunteers
M. Judith Peterschmitt et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2021)
Novel β-Glucocerebrosidase Activators That Bind to a New Pocket at a Dimer Interface and Induce Dimerization
Joerg Benz et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2021)
Genetic Analysis of Prosaposin, the Lysosomal Storage Disorder Gene in Parkinson's Disease
Yong-Ping Chen et al.
MOLECULAR NEUROBIOLOGY (2021)
Upgrading the evidence for the use of ambroxol in Gaucher disease and GBA related Parkinson: Investigator initiated registry based on real life data
Majdolen Istaiti et al.
AMERICAN JOURNAL OF HEMATOLOGY (2021)
A randomized single and multiple ascending dose study in healthy volunteers of LTI-291, a centrally penetrant glucocerebrosidase activator
Jonas M. den Heijer et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2021)
Ambroxol increases glucocerebrosidase (GCase) activity and restores GCase translocation in primary patient-derived macrophages in Gaucher disease and Parkinsonism
A. E. Kopytova et al.
PARKINSONISM & RELATED DISORDERS (2021)
Enzyme replacement therapy with recombinant pro-CTSD (cathepsin D) corrects defective proteolysis and autophagy in neuronal ceroid lipofuscinosis
Andre R. A. Marques et al.
AUTOPHAGY (2020)
Parkinson Disease Epidemiology, Pathology, Genetics, and Pathophysiology
David K. Simon et al.
CLINICS IN GERIATRIC MEDICINE (2020)
Genetic, Structural, and Functional Evidence Link TMEM175 to Synucleinopathies
Lynne Krohn et al.
ANNALS OF NEUROLOGY (2020)
Genetic modifiers of risk and age at onset in GBA associated Parkinson's disease and Lewy body dementia
Cornelis Blauwendraat et al.
BRAIN (2020)
Glucocerebrosidase activity, cathepsin D and monomeric α-synuclein interactions in a stem cell derived neuronal model of a PD associated GBA1 mutation
Shi-yu Yang et al.
NEUROBIOLOGY OF DISEASE (2020)
Glucocerebrosidase Activity Modulates Neuronal Susceptibility to Pathological α-Synuclein Insult
Michael X. Henderson et al.
NEURON (2020)
Variants in saposin D domain of prosaposin gene linked to Parkinson's disease
Yutaka Oji et al.
BRAIN (2020)
Ambroxol for the Treatment of Patients With Parkinson Disease With and Without Glucocerebrosidase Gene Mutations A Nonrandomized, Noncontrolled Trial
Stephen Mullin et al.
JAMA NEUROLOGY (2020)
Lysosomal Exocytosis, Exosome Release and Secretory Autophagy: The Autophagic- and Endo-Lysosomal Systems Go Extracellular
Sandra Buratta et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Genetic perspective on the synergistic connection between vesicular transport, lysosomal and mitochondrial pathways associated with Parkinson's disease pathogenesis
Stefanie Smolders et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2020)
Cathepsin B in neurodegeneration of Alzheimer's disease, traumatic brain injury, and related brain disorders
Vivian Hook et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2020)
Pro-cathepsin D, Prosaposin, and Progranulin: Lysosomal Networks in Parkinsonism
Nahid Tayebi et al.
TRENDS IN MOLECULAR MEDICINE (2020)
Single-Cell Transcriptomics of Parkinson's Disease Human In Vitro Models Reveals Dopamine Neuron-Specific Stress Responses
Hugo J. R. Fernandes et al.
CELL REPORTS (2020)
Current Evidence for a Bidirectional Loop Between the Lysosome and Alpha-Synuclein Proteoforms
Norelle C. Wildburger et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
The Emerging Role of the Lysosome in Parkinson's Disease
Alba Navarro-Romero et al.
CELLS (2020)
Ambroxol as a novel disease-modifying treatment for Parkinson's disease dementia: protocol for a single-centre, randomized, double-blind, placebo-controlled trial
C. R. A. Silveira et al.
BMC NEUROLOGY (2019)
Emerging links between pediatric lysosomal storage diseases and adult parkinsonism
Daniel Ysselstein et al.
MOVEMENT DISORDERS (2019)
Mechanism of glucocerebrosidase activation and dysfunction in Gaucher disease unraveled by molecular dynamics and deep learning
Raquel Romero et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
LRRK2 interacts with the vacuolar-type H+-ATPase pump a1 subunit to regulate lysosomal function
Rebecca Wallings et al.
HUMAN MOLECULAR GENETICS (2019)
C-terminal -synuclein truncations are linked to cysteine cathepsin activity in Parkinson's disease
Ryan P. McGlinchey et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Increased Lysosomal Exocytosis Induced by Lysosomal Ca2+ Channel Agonists Protects Human Dopaminergic Neurons from α-Synuclein Toxicity
Taiji Tsunemi et al.
JOURNAL OF NEUROSCIENCE (2019)
Development and biochemical characterization of a mouse model of Parkinson's disease bearing defective glucocerebrosidase activity
Liudmila Mus et al.
NEUROBIOLOGY OF DISEASE (2019)
Dihydromyricetin and Salvianolic acid B inhibit alpha-synuclein aggregation and enhance chaperone-mediated autophagy
Jia-Zhen Wu et al.
TRANSLATIONAL NEURODEGENERATION (2019)
Lysosomes as a therapeutic target
Srinivasa Reddy Bonam et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Autophagy lysosomal pathway dysfunction in Parkinson's disease; evidence from human genetics
Konstantin Senkevich et al.
PARKINSONISM & RELATED DISORDERS (2019)
Acidifying Endolysosomes Prevented Low-Density Lipoprotein-Induced Amyloidogenesis
Liang Hui et al.
JOURNAL OF ALZHEIMERS DISEASE (2019)
Is Parkinson's disease a lysosomal disorder?
Andres D. Klein et al.
BRAIN (2018)
Sequencing of the GBA coactivator, Saposin C, in Parkinson disease
Bouchra Ouled Amar Bencheikh et al.
NEUROBIOLOGY OF AGING (2018)
Reversible Conformational Conversion of alpha-Synuclein into Toxic Assemblies by Glucosylceramide
Friederike Zunke et al.
NEURON (2018)
Upregulation of PSMB8 and cathepsins in the human brains of dementia with Lewy bodies
Qunxing Ding et al.
NEUROSCIENCE LETTERS (2018)
Analysis of age-related changes in psychosine metabolism in the human brain
Michael S. Marshall et al.
PLOS ONE (2018)
C-terminal truncation of alpha-synuclein promotes amyloid fibril amplification at physiological pH
Ingrid M. van der Wateren et al.
CHEMICAL SCIENCE (2018)
Harnessing Lysosomal pH through PLGA Nanoemulsion as a Treatment of Lysosomal-Related Neurodegenerative Diseases
Geoffrey Prevot et al.
BIOCONJUGATE CHEMISTRY (2018)
Coding variation in GBA explains the majority of the SYT11-GBA Parkinson's disease GWAS locus
Cornelis Blauwendraat et al.
MOVEMENT DISORDERS (2018)
Structural basis for PtdInsP2-mediated human TRPML1 regulation
Michael Fine et al.
NATURE COMMUNICATIONS (2018)
Glucosylsphingosine Promotes α-Synuclein Pathology in Mutant GBA-Associated Parkinson's Disease
Yumiko V. Taguchi et al.
JOURNAL OF NEUROSCIENCE (2017)
Lysosomal processing of progranulin
Xiaolai Zhou et al.
MOLECULAR NEURODEGENERATION (2017)
The lysosomal potassium channel TMEM175 adopts a novel tetrameric architecture
Changkeun Lee et al.
NATURE (2017)
A meta-analysis of genome-wide association studies identifies 17 new Parkinson's disease risk loci
Diana Chang et al.
NATURE GENETICS (2017)
Glucosylceramide synthase inhibition alleviates aberrations in synucleinopathy models
S. Pablo Sardi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
TMEM175 deficiency impairs lysosomal and mitochondrial function and increases α-synuclein aggregation
Sarah Jinn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Evidence for Intramolecular Antiparallel Beta-Sheet Structure in Alpha-Synuclein Fibrils from a Combination of Two-Dimensional Infrared Spectroscopy and Atomic Force Microscopy
Steven J. Roeters et al.
SCIENTIFIC REPORTS (2017)
Excessive burden of lysosomal storage disorder gene variants in Parkinson's disease
Laurie A. Robak et al.
BRAIN (2017)
Lysosomal storage and impaired autophagy lead to inflammasome activation in Gaucher macrophages
Elma Aflaki et al.
AGING CELL (2016)
Impact of lysosome status on extracellular vesicle content and release
Erez Eitan et al.
AGEING RESEARCH REVIEWS (2016)
Nanoparticles restore lysosomal acidification defects: Implications for Parkinson and other lysosomal-related diseases
Mathieu Bourdenx et al.
AUTOPHAGY (2016)
Exocytosis and Spreading of Normal and Aberrant α-Synuclein
Evangelia Emmanouilidou et al.
BRAIN PATHOLOGY (2016)
A New Glucocerebrosidase Chaperone Reduces α-Synuclein and Glycolipid Levels in iPSC-Derived Dopaminergic Neurons from Patients with Gaucher Disease and Parkinsonism
Elma Aflaki et al.
JOURNAL OF NEUROSCIENCE (2016)
Beyond Krabbe's Disease: The Potential Contribution of Galactosylceramidase Deficiency to Neuronal Vulnerability in Late-Onset Synucleinopathies
Michael S. Marshall et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2016)
Parkinson disease-linked GBA mutation effects reversed by molecular chaperones in human cell and fly models
Alvaro Sanchez-Martinez et al.
SCIENTIFIC REPORTS (2016)
mTOR independent regulation of macroautophagy by Leucine Rich Repeat Kinase 2 via Beclin-1
Claudia Manzoni et al.
SCIENTIFIC REPORTS (2016)
Sustained Systemic Glucocerebrosidase Inhibition Induces Brain α-Synuclein Aggregation, Microglia and Complement C1q Activation in Mice
Emily M. Rocha et al.
ANTIOXIDANTS & REDOX SIGNALING (2015)
Dissociation of glucocerebrosidase dimer in solution by its co-factor, saposin C
James M. Gruschus et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
TMEM175 Is an Organelle K+ Channel Regulating Lysosomal Function
Chunlei Cang et al.
CELL (2015)
Role of LIMP-2 in the intracellular trafficking of β-glucosidase in different human cellular models
Erika Malini et al.
FASEB JOURNAL (2015)
α-Synuclein-Independent Histopathological and Motor Deficits in Mice Lacking the Endolysosomal Parkinsonism Protein Atp13a2
Lauren R. Kett et al.
JOURNAL OF NEUROSCIENCE (2015)
Definition of a Molecular Pathway Mediating α-Synuclein Neurotoxicity
Jacqueline Burre et al.
JOURNAL OF NEUROSCIENCE (2015)
Pharmacological Chaperone Therapy: Preclinical Development, Clinical Translation, and Prospects for the Treatment of Lysosomal Storage Disorders
Giancarlo Parenti et al.
MOLECULAR THERAPY (2015)
Lysosomal-associated membrane protein 2 isoforms are differentially affected in early Parkinson's disease
Karen E. Murphy et al.
MOVEMENT DISORDERS (2015)
Lipid vesicles trigger α-synuclein aggregation by stimulating primary nucleation
Celine Galvagnion et al.
NATURE CHEMICAL BIOLOGY (2015)
α-Synuclein-induced dopaminergic neurodegeneration in a rat model of Parkinson's disease occurs independent of ATP13A2 (PARK9)
Guillaume Daniel et al.
NEUROBIOLOGY OF DISEASE (2015)
Ambroxol-induced rescue of defective glucocerebrosidase is associated with increased LIMP-2 and saposin C levels in GBA1 mutant Parkinson's disease cells
Giulia Ambrosi et al.
NEUROBIOLOGY OF DISEASE (2015)
Lysosomal enzyme cathepsin B enhances the aggregate forming activity of exogenous α-synuclein fibrils
Atsushi Tsujimura et al.
NEUROBIOLOGY OF DISEASE (2015)
Genetic and Chemical Activation of TFEB Mediates Clearance of Aggregated α-Synuclein
Kiri Kilpatrick et al.
PLOS ONE (2015)
Cysteine cathepsins are essential in lysosomal degradation of α-synuclein
Ryan P. McGlinchey et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Progressive decline of glucocerebrosidase in aging and Parkinson's disease
Emily M. Rocha et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2015)
Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies
Aaron Ciechanover et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2015)
Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson's disease
Karen E. Murphy et al.
BRAIN (2014)
Glucocerebrosidase is shaking up the synucleinopathies
Marina Siebert et al.
BRAIN (2014)
Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells
Alisdair McNeill et al.
BRAIN (2014)
Parkinson's disease-linked human PARK9/ATP13A2 maintains zinc homeostasis and promotes α-Synuclein externalization via exosomes
Stephanie M. Y. Kong et al.
HUMAN MOLECULAR GENETICS (2014)
ATP13A2/PARK9 Regulates Secretion of Exosomes and α-Synuclein
Taiji Tsunemi et al.
JOURNAL OF NEUROSCIENCE (2014)
Neuronal inclusions of α-synuclein contribute to the pathogenesis of Krabbe disease
Benjamin R. Smith et al.
JOURNAL OF PATHOLOGY (2014)
Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease
Mike A. Nalls et al.
NATURE GENETICS (2014)
The Biogenesis of Lysosomes and Lysosome-Related Organelles
J. Paul Luzio et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2014)
Boosting chaperone-mediated autophagy in vivo mitigates α-synuclein-induced neurodegeneration
Maria Xilouri et al.
BRAIN (2013)
Atp13a2-deficient mice exhibit neuronal ceroid lipofuscinosis, limited -synuclein accumulation and age-dependent sensorimotor deficits
Patrick J. Schultheis et al.
HUMAN MOLECULAR GENETICS (2013)
TFEB-mediated autophagy rescues midbrain dopamine neurons from α-synuclein toxicity
Mickael Decressac et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains
Matthew E. Gegg et al.
ANNALS OF NEUROLOGY (2012)
Lysosomal Acidification Mechanisms
Joseph A. Mindell
ANNUAL REVIEW OF PHYSIOLOGY, VOL 74 (2012)
Gaucher Disease Glucocerebrosidase and α-Synuclein Form a Bidirectional Pathogenic Loop in Synucleinopathies
Joseph R. Mazzulli et al.
CELL (2011)
Extracellular progranulin protects cortical neurons from toxic insults by activating survival signaling
Jindong Xu et al.
NEUROBIOLOGY OF AGING (2011)
CNS expression of glucocerebrosidase corrects α-synuclein pathology and memory in a mouse model of Gaucher-related synucleinopathy
S. Pablo Sardi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
TFEB Links Autophagy to Lysosomal Biogenesis
Carmine Settembre et al.
SCIENCE (2011)
Chaperone-Mediated Autophagy Markers in Parkinson Disease Brains
Lydia Alvarez-Erviti et al.
ARCHIVES OF NEUROLOGY (2010)
Chaperone-mediated autophagy: selectivity pays off
Ana Maria Cuervo
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2010)
Integration of Clearance Mechanisms: The Proteasome and Autophagy
Esther Wong et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease
Juliane Neumann et al.
BRAIN (2009)
Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function
Paul Saftig et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)
Alpha-synuclein-glucocerebrosidase interactions in pharmacological Gaucher models: A biological link between Gaucher disease and parkinsonism
Amy B. Manning-Bog et al.
NEUROTOXICOLOGY (2009)
Abberant α-Synuclein Confers Toxicity to Neurons in Part through Inhibition of Chaperone-Mediated Autophagy
Maria Xilouri et al.
PLOS ONE (2009)
Cathepsin D is the main lysosomal enzyme involved in the degradation of α-synuclein and generation of its carboxy-terminally truncated species
Daniel Sevlever et al.
BIOCHEMISTRY (2008)
Wild type α-synuclein is degraded by chaperone-mediated autophagy and macroautophagy in neuronal cells
Tereza Vogiatzi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Lysosomal membrane permeabilization in cell death
P. Boya et al.
ONCOGENE (2008)
Lysosomal enzyme cathepsin D protects against alpha-synuclein aggregation and toxicity
Liyan Qiao et al.
Molecular Brain (2008)
Gaucher disease
Terry D. Butters
CURRENT OPINION IN CHEMICAL BIOLOGY (2007)
Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase
Alfredo Ramirez et al.
NATURE GENETICS (2006)
Cathepsin B and tumor proteolysis: contribution of the tumor microenvironment
BF Sloane et al.
SEMINARS IN CANCER BIOLOGY (2005)
Impaired degradation of mutant α-synuclein by chaperone-mediated autophagy
AM Cuervo et al.
SCIENCE (2004)
Impact of the acidic C-terminal region comprising amino acids 109-140 on α-synuclein aggregation in vitro
W Hoyer et al.
BIOCHEMISTRY (2004)
Role of α-synuclein carboxy-terminus on fibril formation in vitro
IVJ Murray et al.
BIOCHEMISTRY (2003)
The formation of highly soluble oligomers of α-synuclein is regulated by fatty acids and enhanced in Parkinson's disease
R Sharon et al.
NEURON (2003)
Residual galactosylsphingosine (psychosine) beta-galactosidase activities and associated GALC mutations in late and very late onset Krabbe disease
K Harzer et al.
CLINICA CHIMICA ACTA (2002)
Age-related decline in chaperone-mediated autophagy
AM Cuervo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
